Polynuclear heterobimetallic coordination cages in which different metal cations are connected within a ligand scaffold are known to adopt a variety of polyhedral architectures, many of which display interesting functions. Within the extensive array of coordination cages incorporating Fe(II) centres reported so far, the majority contain low-spin (LS) Fe(II), with high-spin (HS) Fe(II) being less common. Herein, we present the synthesis and characterisation of a new tetradecanuclear heterobimetallic [Fe8Pd6L8](BF4]28 (1) cubic cage utilising the metalloligand approach. Use of the tripodal tris-imidazolimine derivative (2) permitted the formation of the tripodal HS Fe(II) metalloligand [FeL](BF4)2·CH3OH (3) that was subsequently used to form the coordination cage 1. Magnetic and structural analyses gave insight into the manner in which the HS environment of the metalloligand was transferred into the cage architecture along with the structural changes that accompanied its occupancy of the eight corners of the discrete cubic structure.
Abstract:The investigation of new spin-crossover (SCO) compounds plays an important role in understanding the key design factors involved, informing the synthesis of materials for future applications in electronic and sensing devices. In this report, three bis- − counter ions and imidazole N-H were present. The three compounds displayed similar spin-transition profiles, with 2 (-S-) possessing the steepest nature. The shape of the spin transition can be altered in this manner, and this is likely due to the subtle effects that the steric nature of the central atom has on the crystal packing (and thus inter-helical Fe-Fe separation), intermolecular interactions and Fe-Fe intra-helical separations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.